Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News MGM RESORTS INTERNATIONAL MGM

MGM Resorts International is a holding company. The Company, through subsidiaries, is a global gaming and entertainment company with domestic and international locations. The Company's segments include Las Vegas Strip Resorts, Regional Operations, and MGM China. The Las Vegas Strip Resorts segment consists of casino resorts: Aria (including Vdara), Bellagio, The Cosmopolitan of Las Vegas; MGM... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (NYSE:MGM)

Casino ETF Keeps Landing On Red

Benzinga.com  September 17, 2014

Bullboard Posts (NYSE:MGM)

This is Going to Change Society: Kevin Harrington Speaks

This is the very exciting part! A breakthrough product!<< View Post To Watch Video >>
Peng26 - April 13, 2023

Kevin Harrington Discusses FSD Pharma

<< View Post To Watch Video >> I believe this new product will aid society in reducing the number of alcohol-related...
KarenCar - April 13, 2023

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

 
KarenCar - July 14, 2022

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

<< View Post To Watch Video >> FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets...
KarenCar - June 3, 2022

FSD Pharma Files Investigational New Drug Application “IND”

KarenCar - June 1, 2022

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

 
KarenCar - May 10, 2022